New eye drop shows promise for glaucoma patients in china
NCT ID NCT06666855
First seen May 20, 2026 · Last updated May 23, 2026 · Updated 1 time
Summary
This study tests a new eye drop called DE-117B for people with open-angle glaucoma or high eye pressure. It aims to see if the drops safely lower eye pressure over time. About 345 adults in China will use the drops daily for at least 4 weeks, with some receiving an active comparator. The goal is to control the condition, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Guizhou Medical University
Guiyang, China
-
Aier Eye Hospital (Liaoning)
Shenyang, China
-
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, China
-
Beijing Hospital
Beijing, China
-
Beijing Tongren Hospital, Capital Medical University
Beijing, China
-
Daqing People's Hospital
Heilongjiang, China
-
Jinan Second People's Hospital (Jinan eye hospital)
Jinan, China
-
Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong
Shantou, China
-
Luoyang third people's hospital
Luoyang, China
-
Peking University Third Hospital
Beijing, China
-
Qingdao Eye Hospital of Shandong First Medical University
Qingdao, China
-
Shanghai Eye Disease Prevention And Treatment Center/Shanghai Eye Hospital
Shanghai, China
-
Shanxi eye hospital
Shanxi, China
-
Shenzhen Eye Hospital
Shenzhen, China
-
The 4th People's Hospital of Shenyang
Shenyang, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
-
The Second Hospital & Clinical Medicial Lanzhou University
Lanzhou, China
-
Tianjin Eye Hospital
Tianjin, China
-
Wuhan Aier Eye Hospital
Wuhan, China
-
Wuhan Puren Hospital
Wuhan, China
-
Wuxi Second People's Hospital
Wuxi, China
-
Zhejiang Provincial People's Hospital
Hangzhou, China
-
Zhongnan Hospital Affiliated to Wuhan University
Wuhan, China
-
Zhongshan Ophthalmic Center
Guangzhou, China
Conditions
Explore the condition pages connected to this study.